LONDON, Feb. 26, 2018 /PRNewswire/ -- Plant Response Biotech will present at CleanEquity®Monaco 2018 on 8th & 9th March at the Fairmont Monte Carlo.
CleanEquity®is an annual invitation-only event hosted by Innovator Capital, the London based specialist investment bank. The conference provides an intimate and collegiate setting for inventors and entrepreneurs to share their stories with delegates - key decision makers looking to assist them with reaching their commercial and strategic goals.
Other partners and sponsors include Prince Albert II of Monaco's Foundation, Covington & Burling, Cision, Cranfield University, easyGroup, Hobbs & Towne, the Monaco Economic Board, Parkview and Shell Foundation.
Plant Response Biotech has been identified by an expert panel as one of the world's most innovative sustainable technology companies and has been selected to present to selected sovereign, corporate, family and professional investors & acquires, policy makers, end users and international trade media.
Plant Response is a plant innate immunity company with a portfolio of commercial products to improve crop health and increase yield. Spanning disease resistance, stress & drought tolerance, and nutrient efficiency, Plant Response helps plants boost their own immunity and better tolerate biotic and abiotic stress. Their proprietary screening platform allows them to develop products with known mechanisms of action.
Compatible with existing crop protection chemistries, Plant Response products are approved and being introduced commercially in key global markets today. The company is led by a team of respected leaders across R&D, agronomy and commercialization and its growth model includes both product development and strategic M&A. Investors to date include Monsanto, Novozymes, Middleland Capital, and Caixa Capital Rise.
More information can be found at www.plantresponse.com
About Innovator Capital
Innovator Capital, established in 2003, is a specialist investment bank advising emerging technology companies on corporate finance, mergers and acquisitions. Its expertise includes intellectual property and multi-national strategic partnering.
SOURCE Innovator Capital
Share this article